Orchestra BioMed Holdings, Inc.
OBIO • NASDAQ • Stock Fundamentals
Orchestra BioMed Holdings, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David Hochman, with a market cap of $243.7M.
Market Cap$243.7M
Employees56.0
CEODavid Hochman
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 12, 2026 · 1 month 2 days agoQ1 2026
View reportNext EarningsAug 11, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Orchestra BioMed Holdings, Inc. FAQ
Common questions about Orchestra BioMed Holdings, Inc.
Orchestra BioMed Holdings, Inc. (OBIO) has a market capitalization of $243.7M and trades on NASDAQ.
Orchestra BioMed Holdings, Inc. has approximately 56 employees.